Professor, Medicine, UCLA School of Medicine
Endocrinology
Dr. Mayer B. Davidson, MD
|
|
Give Review
Doctor Mayer B. Davidson, MD practices Endocrinology. He studied medicine at Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He has 2 awards "Elected Member" and "Whos Who in Medicine and Healthcare". Mayer B. Davidson is a published doctor as well. He has 68 publications published. The latest was: Response to comment on grunberger "insulin analogs-are they worth it? Yes!" diabetes care 2014;37:1767-1770 and davidson "insulin analogs-is there a compelling case to... Mayer Davidson accepts Medicare payments and is registered with Medicare.gov.
Publications
- Response to comment on grunberger "insulin analogs-are they worth it? Yes!" Diabetes care 2014;37:1767-1770 and davidson "insulin analogs-is there a compelling case to...
- Rationale, design, and implementation of a cluster randomized trial using certified Diabetes educators to intensify treatment for glycemia, blood pressure and lipid co...
- Effect of Long Term Vitamin D Supplementation on Biomarkers of Inflammation in Latino and African-American Subjects with Pre-Diabetes and Hypovitaminosis D.
- Insulin analogs-is there a compelling case to use them? No!
- Epidemiological ramifications of diagnosing Diabetes with HbA1c levels.
- Comment on: Hellemons et al. Initial Angiotensin Receptor Blockade-Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patien...
- Sitagliptin Compared to Thiazolidinediones as a Third-Line Oral Anti-Hyperglycemic Agent in Type 2 Diabetes Mellitus.
- Collaborative care for depression and chronic illnesses.
- A Stepwise Approach to Insulin Therapy in Patients with Type 2 Diabetes Failing Basal Insulin Treatment.
- Diagnosing Diabetes with glucose criteria: worshiping a false God.
- Integrating nurse-directed Diabetes management into a primary care setting.
- Counterpoint: postprandial glucose levels are not a clinically important treatment target.
- Correction to the 2010 report on the diagnosis and classification of Diabetes.
- U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant Type 2 diabetic patients.
- Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with Diabetes: a randomized, double-blind, p...
- Novel noninvasive breath test method for screening individuals at risk for Diabetes: response to Dillon et al.
- How our current medical care system fails people with Diabetes: lack of timely, appropriate clinical decisions.
- Detailed treatment algorithms for effective nurse- and pharmacist-directed Diabetes care: a personal approach.
- No need for the needle (at first).
- A new look at screening and diagnosing Diabetes mellitus.
- Metformin does not suppress thyrotropin.
- Management of hyperglycemia in type 2 Diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus st...
- Utility of A1C for Diabetes screening in the 1999 2004 NHANES population.
- Clinical implications of the DREAM Study.
- Effect of a nurse-directed Diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population.
- Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant Type 2 diabetic patients.
- Does the metabolic syndrome exist: response to Grundy.
- Management of hyperglycemia in type 2 Diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes As...
- Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 Diabetes.
- Effective Diabetes care by a registered nurse following treatment algorithms in a minority population.
- Recommendations for management of Diabetes during Ramadan.
- Efforts to improve subsequent treatment of cardiovascular risk factors in older patients with Diabetes hospitalized for a cardiac event.
- Self-monitoring of blood glucose in patients with type 2 Diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al.
- The effect of disease management programs for patients with Diabetes mellitus on processes and outcomes of care.
- Counterpoint: Self-monitoring of blood glucose in Type 2 diabetic patients not receiving insulin: a waste of money.
- SF-36 and Diabetes outcome measures.
- The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial.
- Glycemia and risk for cardiovascular disease.
- Starting insulin therapy in Type 2 diabetic patients: does it really matter how?
- Thiazolidinediones.
- For the patient. Managing Diabetes with cultural sensitivity and self-empowerment.
- Early insulin therapy for Type 2 diabetic patients: more cost than benefit.
- Using focus groups of older African Americans and Latinos with Diabetes to modify a self-care empowerment intervention.
- Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients.
- Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 Diabetes mellitus.
- Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a...
- Triple therapy: definitions, application, and treating to target.
- Twice-Daily NPH or mixture insulins versus triple therapy: apples versus oranges: response to Poulsen et al.
- Status of research funding by the American Diabetes Association--5th and final year.
- More evidence to support "outsourcing" of Diabetes care.
- Novel risk factors for atherosclerosis.
- Lowering the criterion for impaired fasting glucose will not provide clinical benefit.
- The impact of using a low-literacy patient education tool on process measures of Diabetes care in a minority population.
- Is treatment of insulin resistance beneficial independent of glycemia?
- Metabolic syndrome/insulin resistance syndrome/pre-Diabetes: new section in Diabetes care.
- Effect of nurse-directed Diabetes care in a minority population.
- Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 Diabetes.
- Status of research funded by the American Diabetes Association--year 4.
- The case for "outsourcing" Diabetes care.
- Tests of glycemia.
- Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study.
- Editor's comment: "It ain't necessarily so".
- Counterpoint: the oral glucose tolerance test is superfluous.
- Treatment decisions for type 2 Diabetes.
- Status of research funded by the American Diabetes Association: year 3.
- Have we got the new diagnostic criteria for Diabetes and impaired glucose states right? No.
- Staying the course--with a few adjustments.
Schools
Harvard Medical School
Cornell Bell Med Center
University Wash Hosps
King Co Hospital
Conditions Treated
- Diabetes Type 2
- Hyperlipidemia
- Hypothyroidism
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
Harborview Medical Center -
University of Washington -
NYU School of Medicine -
Harvard Medical School
Drug Facts
| NPI NUMBER | 1154430783 | |
| NPPES Provider LastName | DAVIDSON | |
| NPPES Provider FirstName | MAYER | |
| NPPES Provider ZIPCode | 900593019 | |
| NPPES Provider State | CA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 1697.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154430783 |
| Last Name Of The Provider | DAVIDSON |
| First Name Of The Provider | MAYER |
| View All |
Similar Doctors
|
|
Dr. Angelita S. Beredo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irving P. Ackerman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rashmi S. Mullur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Masahiro Sugawara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mariola L. Ficinski, MD
This Doctor is OpenDoctor Recommended.
|